Literature DB >> 22835890

Male vaccination against human papillomavirus.

David M Salisbury1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22835890     DOI： 10.1016/S1473-3099(12)70082-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Vaccinating women previously exposed to human papillomavirus: a cost-effectiveness analysis of the bivalent vaccine.

Authors:  Hugo C Turner; Iacopo Baussano; Geoff P Garnett
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

2.  Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.

Authors:  Anne Szarewski; S Rachel Skinner; Suzanne M Garland; Barbara Romanowski; Tino F Schwarz; Dan Apter; Song-Nan Chow; Jorma Paavonen; M Rowena Del Rosario-Raymundo; Julio C Teixeira; Newton S De Carvalho; Maria Castro-Sanchez; Xavier Castellsagué; Willy A J Poppe; Philippe De Sutter; Warner Huh; Archana Chatterjee; Wiebren A Tjalma; Ronald T Ackerman; Mark Martens; Kim A Papp; Jose Bajo-Arenas; Diane M Harper; Aureli Torné; Marie-Pierre David; Frank Struyf; Matti Lehtinen; Gary Dubin
Journal:  J Infect Dis       Date:  2013-11-01       Impact factor: 5.226

3.  Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model.

Authors:  Iacopo Baussano; Joakim Dillner; Fulvio Lazzarato; Guglielmo Ronco; Silvia Franceschi
Journal:  Infect Agent Cancer       Date:  2014-01-20       Impact factor: 2.965
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.